Sonic Healthcare Ltd
SHL: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| DGJ | LOCK|yQkgk | LOCK|%h&hcJ |
Sonic Healthcare: Reassuring Organic Growth as Efficiency Grind Continues
Sonic Healthcare reaffirms fiscal 2027 underlying EBITDA guidance of AUD 1.95 billion to AUD 2.03 billion at constant currency. In the four months to October, organic revenue growth was 4.4%, led by Australia, while Switzerland was the laggard.
